Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver
Open Access
- 18 July 2014
- journal article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 14 (1), 518
- https://doi.org/10.1186/1471-2407-14-518
Abstract
Colorectal cancer is the third most frequently diagnosed cancer and the third cause of cancer deaths in the United States. Despite the fact that tumor cell-intrinsic mechanisms controlling colorectal carcinogenesis have been identified, novel prognostic and diagnostic tools as well as novel therapeutic strategies are still needed to monitor and target colon cancer progression. We and others have previously shown, using mouse models, that the extracellular matrix (ECM), a major component of the tumor microenvironment, is an important contributor to tumor progression. In order to identify candidate biomarkers, we sought to define ECM signatures of metastatic colorectal cancers and their metastases to the liver. We have used enrichment of extracellular matrix (ECM) from human patient samples and proteomics to define the ECM composition of primary colon carcinomas and their metastases to liver in comparison with normal colon and liver samples. We show that robust signatures of ECM proteins characteristic of each tissue, normal and malignant, can be defined using relatively small samples from small numbers of patients. Comparisons with gene expression data from larger cohorts of patients confirm the association of subsets of the proteins identified by proteomic analysis with tumor progression and metastasis. The ECM protein signatures of metastatic primary colon carcinomas and metastases to liver defined in this study, offer promise for development of diagnostic and prognostic signatures of metastatic potential of colon tumors. The ECM proteins defined here represent candidate serological or tissue biomarkers and potential targets for imaging of occult metastases and residual or recurrent tumors and conceivably for therapies. Furthermore, the methods described here can be applied to other tumor types and can be used to investigate other questions such as the role of ECM in resistance to therapy.Keywords
This publication has 32 references indexed in Scilit:
- Periostin, a multifunctional matricellular protein in inflammatory and tumor microenvironmentsMatrix Biology, 2014
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- The genetics of hereditary colon cancerGenes & Development, 2007
- Impact of the non‐cellular tumor microenvironment on metastasis: Potential therapeutic and imaging opportunitiesJournal of Cellular Physiology, 2007
- Whole genome analysis for liver metastasis gene signatures in colorectal cancerInternational Journal of Cancer, 2007
- TIMP-1 Is Significantly Associated with Objective Response and Survival in Metastatic Colorectal Cancer Patients Receiving Combination of Irinotecan, 5-Fluorouracil, and Folinic AcidClinical Cancer Research, 2007
- Osteopontin: role in cell signaling and cancer progressionTrends in Cell Biology, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathwayCancer Cell, 2004
- Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer.2002